|
|
|
|
| LEADER |
03107nam a2200553 i 4500 |
| 001 |
1343956137 |
| 003 |
OCoLC |
| 005 |
20220908131725.0 |
| 006 |
m o d f |
| 007 |
cr ||||||||||| |
| 008 |
220908s2022 dcua ob f000 0 eng c |
| 024 |
8 |
|
|a 43-881
|q (GPO jacket number)
|
| 040 |
|
|
|a GPO
|b eng
|e rda
|e pn
|c GPO
|d GPO
|d MvI
|
| 042 |
|
|
|a pcc
|
| 043 |
|
|
|a n-us---
|
| 049 |
|
|
|a COM7
|
| 074 |
|
|
|a 1019-C-01 (online)
|
| 086 |
0 |
|
|a Y 4.C 73/8:116-76
|
| 088 |
|
|
|a Serial no. 116-76 (United States. Congress. House. Committee on Energy and Commerce)
|
| 110 |
1 |
|
|a United States.
|b Congress.
|b House.
|b Committee on Energy and Commerce.
|b Subcommittee on Health,
|e author.
|
| 245 |
1 |
0 |
|a Safeguarding pharmaceutical supply chains in a global economy :
|b hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, October 30, 2019.
|
| 264 |
|
1 |
|a Washington :
|b U.S. Government Publishing Office,
|c 2022.
|
| 300 |
|
|
|a 1 online resource (vi, 176 pages) :
|b color illustrations.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent.
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia.
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier.
|
| 500 |
|
|
|a Access ID (govinfo): CHRG-116hhrg43881.
|
| 500 |
|
|
|a "Serial no. 116-76."
|
| 500 |
|
|
|a GPO Cataloging Record Distribution Program (CRDP).
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 511 |
0 |
|
|a Hearing witnesses: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research, Food and Drug Administration, Department of Health and Human Services; Michael R. Wessel, Commissioner, U.S.-China Economic and Security Review Commission; Rosemary Gibson, Senior Advisor, The Hastings Center; Edward Price, President and Chief Executive Officer, Seqens N.A; David Gaugh, R.Ph., Senior Vice President, Sciences and Regulatory Affairs, Association for Accessible Medicines.
|
| 518 |
|
|
|a Date of hearing: 2019-10-30.
|
| 588 |
|
|
|a Description based on online resource; title from PDF title page (GovInfo, viewed Sep. 8, 2022).
|
| 650 |
|
0 |
|a Prescription pricing
|x Government policy
|z United States.
|
| 650 |
|
0 |
|a Drugs
|x Prices
|z United States.
|
| 650 |
|
0 |
|a Drugs
|z United States
|x Cost control.
|
| 650 |
|
0 |
|a Drugs
|x Law and legislation
|z United States.
|
| 650 |
|
0 |
|a Pharmaceutical industry
|z United States.
|
| 655 |
|
7 |
|a Legislative hearings.
|2 lcgft.
|
| 776 |
0 |
8 |
|i Print version:
|a United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
|t Safeguarding pharmaceutical supply chains in a global economy
|w (OCoLC)1343956054.
|
| 856 |
4 |
0 |
|u https://purl.fdlp.gov/GPO/gpo186472
|7 0
|
| 907 |
|
|
|a .b65711051
|b cug
|c -
|d 221018
|e 221201
|
| 998 |
|
|
|a cug
|b 221018
|c m
|d a
|e -
|f eng
|g dcu
|h 0
|i 1
|
| 922 |
|
|
|a GOVINFOHRG
|
| 922 |
|
|
|a BIBCONEW
|b 20220908
|
| 948 |
|
|
|a MARCIVE Over, in 2022.11
|
| 995 |
|
|
|a Loaded with m2btab.ltiac in 2022.11
|
| 995 |
|
|
|a Loaded with m2btab.msgov7 in 2022.10
|
| 989 |
|
|
|a Y 4.C 73/8:116-76
|d cuege
|e - -
|f - -
|g j
|h 0
|i 0
|j 216
|k 221018
|l $0.00
|m
|n - -
|o -
|p 0
|q 0
|t 0
|x 0
|w US Gov Docs
|1 .i144278042
|